Author

Michael Drennan

PRECLINICAL IN VITRO AND IN VIVO INVESTIGATION OF THE FIRST-IN-CLASS SELECTIVE SIK2/SIK3 INHIBITOR GLPG3970 IN EXPERIMENTAL MODELS OF IBD
PRECLINICAL IN VITRO AND IN VIVO INVESTIGATION OF THE FIRST-IN-CLASS SELECTIVE SIK2/SIK3 INHIBITOR GLPG3970 IN EXPERIMENTAL MODELS OF IBD

Michael Drennan  et al.

Item 1 - 1 / 1
1